Strategic partnership will enable more than a billion peptides to be cataloged to enable the discovery of new protein variants and novel biomarkers leading to therapeutic breakthroughs
Through this multi-year effort, Seer and Sciex will contribute industry-leading proprietary proteomics technologies, and DLS will provide its significant scale and expertise in genomic services and biospecimens, to provide services that support population scale plasma proteogenomic projects.
Therefore, we support and empower them in their personal lives and quest for professional growth. We are in search of team members who value diversity and are passionate about making a difference in patients’ lives. We offer competitive compensation and benefits, and hire based on talents, potential and alignment on shared values when it comes towards delivering results while demonstrating collaborative behaviors. We encourage you to apply to become a part of our team!
With a phased approach to building a 100,000 sample per- year capacity, the Proteogenomics Consortium will create the capacity, workflows, and expertise to run large scale proteogenomic projects efficiently, quickly and robustly. Through the consortium there is also an opportunity for future collaborations to further pave the way for adoption of proteogenomics via workflow optimization, joint publications and development of novel applications.
Join Discovery Life Sciences at Phacilitate's Advanced Therapies Week 2025, Jan 20-23 in Dallas! Visit us at Booth 161 and join Dr. Yuki Maves' presentation on Jan 23. Supply Chain: Future of Apheresis & Collections Location: Theater 5 Date/Time: Jan 23, Time TBD
Join Discovery at Precision Medicine Tri-Con 2025.
Join Discovery at World CB & CDx Summit Europe 2025.
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
